Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mark P Hamilton

1PUBLICATIONS

25CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 08, 2025

Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Yi-Jiun Su, Anne Marijn Kramer, Mark P Hamilton

Pageof 1

Frequent Collaborators

1 joint publications

Yi-Jiun Su

1 joint publications

Anne Marijn Kramer

1 joint publications

Neha Agarwal

1 joint publications

Hrishikesh K Srinagesh

1 joint publications

John H Baird

1 joint publications

Bita Sahaf

1 joint publications

Adam Kuo

1 joint publications

Zachary J Ehlinger

1 joint publications

Moksha H Desai

1 joint publications

Skyler P Rietberg

Frequent Collaborators

1 joint publications

Yi-Jiun Su

1 joint publications

Anne Marijn Kramer

1 joint publications

Neha Agarwal

1 joint publications

Hrishikesh K Srinagesh

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

See more related videos